Death marks second fatality in growing outbreak, following the death of an unvaccinated school-aged child in Texas ...
The makers of 2 popular weight-loss drugs — Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the Danish company behind ...
(HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
More frequent placement of central venous catheter seen for patients with heart failure with reduced ejection fraction ...
Patients with SLE vs individuals without autoimmune disease demonstrated higher rates of peripartum complications.
On February 7, the NIH announced that it would begin capping indirect cost payments for new and existing research grants at 15%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback